Venus Remedies Limited

NSE VENUSREM.NS

Venus Remedies Limited Net Income Margin for the year ending March 31, 2024: 4.82%

Venus Remedies Limited Net Income Margin is 4.82% for the year ending March 31, 2024, a 0.71% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Venus Remedies Limited Net Income Margin for the year ending March 31, 2023 was 4.78%, a -29.69% change year over year.
Venus Remedies Limited Net Income Margin for the year ending March 31, 2022 was 6.80%, a -39.63% change year over year.
Venus Remedies Limited Net Income Margin for the year ending March 31, 2021 was 11.27%, a 479.36% change year over year.
Venus Remedies Limited Net Income Margin for the year ending March 31, 2020 was -2.97%, a 67.00% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NSE: VENUSREM.NS

Venus Remedies Limited

CEO	Mr. Ashutosh Jain B.A., LL.B
IPO Date	Dec. 20, 2006
Location	India
Headquarters	Plot 51-52, Industrial Area
Employees	1,187
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, anticoagulant, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin and wound care, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Key trends

Past 5 years